4L52

Crystal Structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}piperidin-1-yl)ethan-1-one bound to TAK1-TAB1

• PDB DOI: https://doi.org/10.2210/pdb4L52/pdb

• Classification: TRANSFERASE/TRANSFERASE INHIBITOR
• Organism(s): Homo sapiens
• Expression System: Spodoptera frugiperda
• Mutation(s): No 


• Deposited: 2013-06-10 Released: 2013-07-03 
• Deposition Author(s): Wang, J., Hornberger, K.R., Crew, A.P., Jestel, A., Maskos, K., Moertl, M.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.54 Å
• R-Value Free: 0.230 
• R-Value Work: 0.195 
• R-Value Observed: 0.196 

Literature

Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1.

Hornberger, K.R., Berger, D.M., Crew, A.P., Dong, H., Kleinberg, A., Li, A.H., Medeiros, M.R., Mulvihill, M.J., Siu, K., Tarrant, J., Wang, J., Weng, F., Wilde, V.L., Albertella, M., Bittner, M., Cooke, A., Gray, M.J., Maresca, P., May, E., Meyn, P., Peick, W., Romashko, D., Tanowitz, M., Tokar, B.

(2013) Bioorg Med Chem Lett 23: 4517-4522

• PubMed: 23850198 
• DOI: https://doi.org/10.1016/j.bmcl.2013.06.053
• Primary Citation of Related Structures:  
  4L3P, 4L52


• PubMed Abstract: 
  

  The discovery and potency optimization of a series of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1 is described. Micromolar hits taken from high-throughput screening were optimized for biochemical and cellular mechanistic potency to ~10nM, as exemplified by compound 12az. Application of structure-based drug design aided by co-crystal structures of TAK1 with inhibitors significantly shortened the number of iterations required for the optimization.

---

Organizational Affiliation: 

OSI Pharmaceuticals LLC, 1 Bioscience Park Drive, Farmingdale, NY 11735, USA. [e-mail]

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 35.17 kDa 
• Atom Count: 2,420 
• Modelled Residue Count: 295 
• Deposited Residue Count: 307 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera	A	307	Homo sapiens	Mutation(s): 0  Gene Names: MAP3K7, TAK1, MAP3K7IP1, TAB1 EC: 2.7.11.25
UniProt & NIH Common Fund Data Resources
Find proteins for Q15750 (Homo sapiens) Explore Q15750  Go to UniProtKB:  Q15750
PHAROS:  Q15750 GTEx:  ENSG00000100324
Find proteins for O43318 (Homo sapiens) Explore O43318  Go to UniProtKB:  O43318
PHAROS:  O43318 GTEx:  ENSG00000135341
UniProt Groups	O43318Q15750

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
1UL	B [auth A]	1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}piperidin-1-yl)ethanone C23 H21 N7 O2 S XDCWLOMVUOZXFY-UHFFFAOYSA-N

Binding Affinity Annotations
ID	Source	Binding Affinity
1UL	BindingDB:  4L52	IC50: min: 4, max: 12 (nM) from 2 assay(s)
	PDBBind:  4L52	IC50: 4 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.54 Å
• R-Value Free: 0.230 
• R-Value Work: 0.195 
• R-Value Observed: 0.196 
• Space Group: I 2 2 2

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 58.16	α = 90
b = 133.784	β = 90
c = 142.237	γ = 90

Software Package:

Software Name	Purpose
MOLREP	phasing
REFMAC	refinement
XDS	data reduction
XSCALE	data scaling

Structure Validation

Entry History 

Deposition Data

• Released Date: 2013-07-03 
Deposition Author(s): Wang, J., Hornberger, K.R., Crew, A.P., Jestel, A., Maskos, K., Moertl, M.

Revision History  

• Version 1.0: 2013-07-03
  Type: Initial release
  
• Version 1.1: 2013-07-31
  Changes: Database references
• Version 1.2: 2013-08-07
  Changes: Database references
• Version 1.3: 2017-07-26
  Changes: Advisory, Refinement description, Source and taxonomy
• Version 1.4: 2017-11-15
  Changes: Refinement description
• Version 1.5: 2024-10-30
  Changes: Advisory, Data collection, Database references, Derived calculations, Structure summary